Skip to main content

Day: April 7, 2020

Copenhagen Capital A/S – Indkaldelse til ordinær generalforsamling

Der indkaldes herved til ordinær generalforsamling i Copenhagen Capital A/S (CVR-nr.: 30731735) onsdag den 29. april 2020 kl. 14.00. Generalforsamlingen afholdes på selskabets adresse Tingskiftevej 5, 2900 Hellerup.På baggrund af COVID-19 og udmeldingerne fra myndighederne om forbud mod forsamlinger på mere end 10 personer, opfordres aktionærerne til ikke at møde op på generalforsamlingen, men benytte sig af muligheden for at afgive brevstemme eller fuldmagt. Generalforsamlingen kan følges via en telekonference dog uden mulighed for at stemme og stille spørgsmål.  Dagsorden:Udpegning af dirigent, jf. vedtægternes § 4.4Bestyrelsens beretning for det forløbne regnskabsårForelæggelse af årsrapporten for 2019 med ledelsesberetning og godkendelse af årsrapportenBeslutning om anvendelse af overskud eller dækning af tab i henhold til den godkendte...

Continue reading

Marrone Bio Announces Introduction of New Synergistic Plant Health Product Available to Corn, Soybean and Wheat Growers

DAVIS, Calif., April 07, 2020 (GLOBE NEWSWIRE) — Marrone Bio Innovations Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced that Pacesetter™, a recently approved bio-based plant health product, is now available to corn, soybean and wheat growers in the United States.Pacesetter acts synergistically with conventional fungicides to improve plant health and vigor, increasing yield by up to seven bushels per acre in soybeans and 13 bushels per acre in corn. The active ingredient in Pacesetter is a plant extract from Reynoutria sachalinensis, a compound that delivers multiple modes of action. When used with conventional fungicides, Pacesetter promotes root growth, and increases chlorophyll production in the crop, resulting in yield increases beyond that of a grower’s standard...

Continue reading

ElectraMeccanica Announces New Cost-Effective Aluminum Chassis for Flagship, Single-Occupant SOLO EV

VANCOUVER, British Columbia, April 07, 2020 (GLOBE NEWSWIRE) — ElectraMeccanica Vehicles Corp. (NASDAQ: SOLO) (“ElectraMeccanica” or the “Company”), a designer and manufacturer of electric vehicles, has announced the engineering and development of a new, cost-effective aluminum chassis for the Company’s flagship, single-occupant SOLO electric vehicle (EV).The new, high strength, drop-in aluminum chassis will replace the current composite chassis in the SOLO EV, making it much better suited for mass production by reducing the overall weight and per-unit assembly cost of the vehicle. ElectraMeccanica has engaged a Tier-One engineering partner with a global presence, which will provide on-the-ground support in both Canada and China.“This project represents our continued focus on evolving the safety, comfort...

Continue reading

Overstock.com Announces Key Dates and Provides Detailed Information Regarding its Digital Series A-1 Preferred Stock Dividend

SALT LAKE CITY, April 07, 2020 (GLOBE NEWSWIRE) — Overstock.com, Inc. (NASDAQ:OSTK) is announcing key dates and releasing the following information for shareholders relating to the recently announced dividend of the Digital Voting Series A-1 Preferred Stock (“Series A-1”) (the “Dividend”), including how the Dividend will be distributed, and the process and mechanics of the Dividend for broker-dealers and other financial professionals.“I am pleased to announce that the Overstock board has declared the Dividend and set the relevant record and payment dates. We are publishing the following detailed information, which I hope will be helpful to shareholders and other market participants,” said Overstock CEO Jonathan Johnson.TimingOn February 13, 2020, the shareholders of Overstock approved amendments to the Company’s Certificate of Incorporation...

Continue reading

Albireo to Present at 19th Annual Needham Healthcare Conference

BOSTON, April 07, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that Simon Harford, Chief Financial Officer, will present via webcast at the 19th Annual Needham Healthcare Conference on Tuesday, April 14, at 2:10 p.m. EDT.The live webcast of the presentation will be accessible from the Media & Investors page of Albireo’s website, ir.albireopharma.com. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of the webcast will be available for replay in the Events & Presentations section of the Media & Investors page of Albireo’s website for at least two weeks following the event.About AlbireoAlbireo...

Continue reading

Jason New Joins as Co-CEO of Onex Credit

All amounts in U.S. dollars unless otherwise statedTORONTO, April 07, 2020 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced Jason New has joined Onex Credit as the Co-Chief Executive Officer. He will lead the platform with Stuart Kovensky. Jason will also be responsible for new strategies in opportunistic credit and special situations.Gerry Schwartz, Chairman and Chief Executive Officer of Onex, commented, “Jason brings an important new dimension to Onex Credit and positions us for growth through a variety of cycles. With his background and skills complementing the already talented group, we feel our leadership team is essentially complete.”Mr. Kovensky said, “Jason is a successful investor and a well-recognized leader in the credit industry who brings to Onex his strong relationships with key sector constituents....

Continue reading

Jones Soda Appoints Jamie Colbourne as Interim CEO

SEATTLE, April 07, 2020 (GLOBE NEWSWIRE) — Jones Soda Co. (the “Company”) (OTCQB: JSDA), a leader in the craft soda industry known for its unique branding and authentic connection to consumers, has appointed Jamie Colbourne as interim CEO effective April 6, 2020. After eight years at the helm, Jennifer Cue has decided to step down from the position of CEO and spend more time with her family. Cue will be available to assist Colbourne when needed and will remain on the Company’s board of directors.Colbourne is an accomplished executive with more than three decades of experience in growing profitable businesses. Most recently, he served as CEO and board member for JGC Foods, a holding company that specializes in the manufacturing and distribution of branded and co-packaged soups, sauces and entrees across North America. While in this...

Continue reading

New Earth Alive EA1™ Trial to Commence at Brazilian Mine

MONTREAL, April 07, 2020 (GLOBE NEWSWIRE) — Earth Alive Clean Technologies Inc. (TSX: EAC) (“Earth Alive” or the “Company”), a Canadian soil health company is pleased to announce a sale agreement (“Agreement”) for its proprietary EA1™ dust suppressant with a major mining operation in Brazil. This trial, the second by this mining group in different geographical locations, is part of the approval process to becoming an important multi-site dust suppressant solution provider for the group.Under the terms of the sale, Earth Alive will conduct a six-week, on-site trial to validate the efficacy of the Company’s proprietary EA1™ dust suppressant at a large open-pit iron-ore mine in Minas Gerais, Brazil.“We are pleased to begin our second trial valued at approximately C$215,000 with this important international mining conglomerate,” said...

Continue reading

La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at University Hospital Münster in Germany

SAN DIEGO, April 07, 2020 (GLOBE NEWSWIRE) — La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced that it is providing GIAPREZA™ (angiotensin II) for named patient emergency use in patients with septic shock due to COVID-19 at University Hospital Münster in Germany. GIAPREZA is being made available for named patient emergency use based on a request from Professor Alexander Zarbock, M.D., Chair, Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital Münster. According to German law, authorized medicines can be made available prior to commercial availability in order to fulfill special patient needs. GIAPREZA has been recently approved...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.